Clinical trial
Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia
NCT06946511 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia
- Lead sponsor
- Ruijin Hospital
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- August 1, 2025
- Completion date
- January 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.